The increasing prevalence of obesity has made nonalcoholic fatty liver disease (NAFLD) the
most common chronic liver disease. As a consequence, NAFLD and especially its …

Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

Since the discovery of adipose tissue as a higly active endocrine tissue, adipokines,
peptides produced by adipose tissue and exerting autocrine, paracrine and endocrine …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome. The underlying causes of the disease progression in NAFLD are unclear. Recent …

Leptin, the first described adipokine, interplays with hepatic metabolism. The aim of this
review was to summarize available data on the association between leptin and nonalcoholic …

Recently, the beneficial effects of increased physical activity (PA) on nonalcoholic fatty liver
disease (NAFLD) in obese subjects were reported. However, the optimal strength and …

Exercise could alleviate non-alcoholic fatty liver disease (NAFLD), but it was not clear which
exercise methods could effectively treat NAFLD. The purpose of this systematic review and …

AIM: To review the effectiveness of exercise as a therapy for nonalcoholic fatty liver disease
(NAFLD) and potential benefits in treating insulin resistance and atherosclerosis …

Obesity is associated with an increased risk of chronic, low-grade systematic inflammation
for which exercise training (EX) and caloric restriction (CR) are potential treatments. We …